Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment

被引：4
|
作者：
Ruiz-Rivero, Juncal [1 ,2 ]
Horcajada-Reales, Celia [1 ,2 ]
Tardio, Juan C. [1 ,3 ]
Manuel Borbujo-Martinez, Jesus [1 ,2 ]
机构：
[1] Hosp Univ Sagrat Cor, Barcelona, Spain
[2] Hosp Univ Fuenlabrada, Dept Clin & Surg Dermatol & Venereol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Dept Pathol Anat, Madrid, Spain
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2018年 / 93卷 / 06期
关键词：
TRASTUZUMAB EMTANSINE;
D O I：
10.1590/abd1806-4841.20187968
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [41] Delayed neurotoxicity in HER2-positive breast cancer: a case series on combined SRS and T-DM1 treatment
    Turna, Menekse
    Caglar, Hale Basak
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice
    Michel, Laura L.
    Bermejo, Justo Lorenzo
    Gondos, Adam
    Marme, Frederik
    Schneeweiss, Andreas
    ANTICANCER RESEARCH, 2015, 35 (09) : 5085 - 5090
  • [43] Meta-analysis of the clinical efficacy and safety of T-DM1 in the treatment of HER2-positive breast cancer
    Liu, Furong
    Li, Yuehua
    Yang, Dinghua
    Tang, Li
    Yang, Qian
    Jiang, Majiao
    Tian, Leilei
    An, Jingjing
    INDIAN JOURNAL OF CANCER, 2024, 61 (01) : 146 - 155
  • [44] Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
    Burris, Howard A., III
    Tibbitts, Jay
    Holden, Scott N.
    Sliwkowski, Mark X.
    Phillips, Gail D. Lewis
    CLINICAL BREAST CANCER, 2011, 11 (05) : 275 - 282
  • [45] Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
    Ma, Bo
    Ma, Qianqian
    Wang, Hongqiang
    Zhang, Guolei
    Zhang, Huiying
    Wang, Xiaohong
    ONCOTARGETS AND THERAPY, 2016, 9 : 959 - 976
  • [46] Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
    Diessner, J.
    Bruttel, V.
    Stein, R. G.
    Horn, E.
    Haeusler, S. F. M.
    Dietl, J.
    Hoenig, A.
    Wischhusen, J.
    CELL DEATH & DISEASE, 2014, 5 : e1149 - e1149
  • [47] RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)
    Berghoff, A. S.
    Bartsch, R.
    Bergen, E.
    Rudas, M.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Steger, G. G.
    Preusser, M.
    NEURO-ONCOLOGY, 2014, 16
  • [48] Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
    Hunter, Francis W.
    Barker, Hilary R.
    Lipert, Barbara
    Rothe, Francoise
    Gebhart, Geraldine
    Piccart-Gebhart, Martine J.
    Sotiriou, Christos
    Jamieson, Stephen M. F.
    BRITISH JOURNAL OF CANCER, 2020, 122 (05) : 603 - 612
  • [49] Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
    Francis W. Hunter
    Hilary R. Barker
    Barbara Lipert
    Françoise Rothé
    Géraldine Gebhart
    Martine J. Piccart-Gebhart
    Christos Sotiriou
    Stephen M. F. Jamieson
    British Journal of Cancer, 2020, 122 : 603 - 612
  • [50] Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
    J Diessner
    V Bruttel
    R G Stein
    E Horn
    S F M Häusler
    J Dietl
    A Hönig
    J Wischhusen
    Cell Death & Disease, 2014, 5 : e1149 - e1149
12345